Excess weight is associated with neurological and neuropsychiatric symptoms in post-COVID-19 condition: A systematic review and meta-analysis
Open Access
- 7 May 2025
- journal article
- review article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (5) , e0314892
Abstract
Background/purpose: Excess weight has been identified as a potential risk factor for post-COVID-19 condition (PCC). This systematic review and meta-analysis aimed to investigate whether excess weight is associated with the development or experience of neurological and neuropsychiatric symptoms in PCC. Methods: We conducted a comprehensive search of eight databases (PubMed, Embase, Scopus, Web of Science, VHL, Google Scholar, ProQuest, and medRxiv) for studies published up to July 2023. Studies were included if they assessed PCC symptoms in relation to nutritional status, specifically the development of neurological and neuropsychiatric symptoms more than 12 weeks post-infection. The analysis compared exposure and controls groups (excess weight vs. normal weight; obesity vs. non-obesity). Data were synthesized using a random-effects model. Results: Of the 10,122 abstracts screened, 18 studies (n = 139,091 adults) were included. These studies included 79,050 individuals with excess weight vs 57,926 normal-weight individuals and 30,694 individuals with obesity vs 107,612 non-obese individuals. The presence of excess weight in PCC was significantly associated with persistent depression (RR = 1.21; 95% CI: 1.03–1.42), headache (OR = 1.23; 95% CI: 1.10–1.37), memory issues (RR = 1.43; 95% CI: 1.24–1.65), sleep disturbance (RR = 1.31; 95% CI: 1.16–1.48), and vertigo (RR = 1.21; 95% CI: 1.04–1.41). Obesity was significantly associated with persistent headache (OR = 1.45; 95% CI: 1.37–1.53), numbness (RR = 1.61; 95% CI: 1.46–1.78), smell disorder (OR = 1.16; 95% CI: 1.11–1.22), taste disorder (OR = 1.22; 95% CI: 1.08–1.38), and vertigo (RR = 1.44; 95% CI: 1.35–1.53). Conclusions: Excess weight, including overweight and obesity, is associated with experiencing neuro-symptoms related to PCC. Individuals with these conditions urgently need enhanced personalized care management in current post-pandemic context.Keywords
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (Finance Code 001)
- Health Sciences Teaching and Research Foundation (5/2020 – FEPECS/DE)
- Western Australian Future Health and Innovation Fund, Government of Western Australia (WANMA/Ideas2023-24/10)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (302740/2022-8)
This publication has 86 references indexed in Scilit:
- Development of a Definition of Postacute Sequelae of SARS-CoV-2 InfectionJAMA, 2023
- Risk Factors Associated With Post−COVID-19 ConditionJAMA Internal Medicine, 2023
- Post–COVID-19 Symptoms 2 Years After SARS-CoV-2 Infection Among Hospitalized vs Nonhospitalized PatientsJAMA Network Open, 2022
- Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021JAMA, 2022
- A cross-sectional study on the mental health of patients with COVID-19 1 year after discharge in Huanggang, ChinaEuropean Archives of Psychiatry and Clinical Neuroscience, 2022
- Long COVID‐19: Objectifying most self‐reported neurological symptomsAnnals of Clinical and Translational Neurology, 2022
- Long-term neurological manifestations of COVID-19: prevalence and predictive factorsNeurological Sciences, 2021
- Long‐term effects of obesity on COVID‐19 patients discharged from hospitalImmunity, Inflammation and Disease, 2021
- Post‐acute COVID‐19 syndrome (PCS) and health‐related quality of life (HRQoL)—A systematic review and meta‐analysisJournal of Medical Virology, 2021
- Persistent Symptoms in Patients After Acute COVID-19JAMA, 2020